reviewWorld PsychiatryFeb 1, 2009BRONZE OA

Metabolic syndrome in people with schizophrenia: a review

KU Leuven · Maastricht University Medical Centre · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

People with severe mental illnesses (SMI), such as schizophrenia, have a reduced life expectancy compared to the general population 1–13. They have a 2–3 fold increased risk of dying, and this mortality gap associated with mental illness compared to the general population has widened in recent decades 13. People with severe mental illness have nearly twice the normal risk of dying from cardiovascular disease (CVD) 1–13. In the psychiatric community, this has led in recent years to a growing concern about physical illness in people with SMI, specifically CVD risk 14–24. People with SMI are more likely to be overweight, to smoke and to have hyper- glycaemia/diabetes, hypertension and dyslipidaemia (Table 1).…

Citation impact

629
total citations
FWCI
23.54
Percentile
100%
References
148
Citations per year

Authors

4

Topics & keywords

Keywords
  • Medicine
  • Metabolic syndrome
  • Antipsychotic
  • Psychiatry
  • Schizophrenia (object-oriented programming)
  • Mental illness
  • Referral
  • Population
UN Sustainable Development Goals
  • No poverty
No related works found for this paper.